Clinical Trial Update: iNO300 Therapy in Critically Ill Patients With Pneumonia [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update indicating that iNO300 Therapy is recruiting for critically ill patients with pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• iNO300 Therapy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Critical Illness, Pneumonia | EARLY_Phase 1 | Status: RECRUITING